IMPORTANT:
You must view the program in its entirety in order to receive full credit. Otherwise, your generated CE statement will produce zero (0) contact hours.
Click on your practice setting below, to launch the webinar.
* Please make sure that your pop-up blocker on your computer is disabled, otherwise you will be required to fill out the form once again.
Target Audience: Pharmacists, Certified Pharmacy Technicians, Nurses, Healthcare Risk Managers
Fees: No Charge
Accreditation
This knowledge-based activity has been accredited for 1.0 contact hours of continuing education credit for pharmacists and pharmacy technicians.
UAN#: 0384-9999-12-002-H05-P / 0384-9999-12-002-H05-T
This webinar is being provided through an educational partnership between Corexcel and STAT Educational Services. Corexcel designates this live activity for 1.0 Contact Hour.
Corexcel is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been approved for a total of 1.0 contact hours of Continuing Education Credit toward fulfillment of the requirements of ASHRM designations of FASHRM (Fellow) and DFASHRM (Distinguished Fellow) and towards CPHRM renewal.
Faculty
Mildred “Millie” A. Toth, MS, RN, AOCN | Senior Nursing Instructor
University of Texas, M. D. Anderson Cancer Center
Houston, Texas
E. Thomas Carey, PharmD| Director of Pharmacy Services
SwedishAmericanHospital
Rockford, IL
Seth Eisenberg, RN, OCN®| Professional Practice Coordinator
Infusion Services from Seattle Cancer Care Alliance
Seattle, WA
Learning Objectives (for all participants)
At the completion of this activity, participants will be able to:
-
Identify the role of NIOSH in relation to Hazardous Drug Safety;
-
Define Hazardous Drugs and potential consequences of exposure;
-
Describe the components to protect staff involved in the preparation of Hazardous Drugs;
-
Describe the definition of a closed-system transfer device;
-
Identify steps to support implementation of the current ASCO/ONS Chemotherapy Administration Safety Standards into practice;
-
Identify some of the challenges experienced by the Washington State department of Labor and Industries working group in making the NIOSH guidelines law;
-
Describe how to financially justify the use of a closed-system transfer device.
Disclosures
• This program has been peer reviewed to ensure accuracy, balance and non-commercialization.
• Commercial support for this program has been provided by BD.
• E. Thomas Carey disclosed being on the Speakers Bureau of BD. Millie Toth and Seth Eisenberg did not have any disclosures to make.
• This program is intended strictly for educational purposes and does not constitute as an endorsement of any product or off-label usage.
Handouts
Handouts and full slides can be printed from the webinar window under the "Links" section.
